Search

Imre Noth Phones & Addresses

  • 3110 Turner Mtn Wood Rd, Charlottesvle, VA 22903 (434) 977-0754
  • Charlottesville, VA
  • 2628 Cortland St, Chicago, IL 60647 (773) 862-2998
  • 5016 S Ellis Ave, Chicago, IL 60615 (773) 624-5181
  • 600 Dearborn St, Chicago, IL 60605 (312) 786-9947
  • Sacramento, CA
  • Pinehurst, TX
  • Scottsdale, AZ
  • Tucson, AZ

Work

Company: University of chicago Position: Associate professor

Education

School / High School: University of California, Davis - School of Medicine 1992 to 1995 Specialities: Residency Internal Medicine

Skills

Clinical Research • Medical Education • Medicine • Internal Medicine • Translational Research • Cancer • Science • Board Certified • Data Analysis • Neuroscience • Life Sciences • Clinical Trials • Hospitals

Ranks

Certificate: American Board of Internal Medicine Sub-certificate in Critical Care Medicine (Internal Medicine)

Industries

Medical Practice

Professional Records

Medicine Doctors

Imre Noth Photo 1

Imre Noth

View page
Specialties:
Pulmonary Critical Care Medicine, Pulmonary Disease
Work:
Center For Advanced Medicine Pulmonary
5758 S Maryland Ave STE 4C, Chicago, IL 60637
(773) 702-9660 (phone), (773) 834-7068 (fax)
Education:
Medical School
University of Arizona College of Medicine at Tucson
Graduated: 1992
Procedures:
Pulmonary Function Tests
Conditions:
Bronchial Asthma
Obstructive Sleep Apnea
Pneumonia
Pulmonary Embolism
Sarcoidosis
Languages:
English
Spanish
Description:
Dr. Noth graduated from the University of Arizona College of Medicine at Tucson in 1992. He works in Chicago, IL and specializes in Pulmonary Critical Care Medicine and Pulmonary Disease. Dr. Noth is affiliated with University Of Chicago Medicine.
Imre Noth Photo 2

Imre Noth, Chicago IL

View page
Specialties:
Internal Medicine
Critical Care Medicine
Pulmonary Disease
Pediatrics
Work:
The University of Chicago Medicine
5841 S Maryland Ave, Chicago, IL 60637
Center For Advanced Medicine
5758 S Maryland Ave, Chicago, IL 60637
Education:
University of Arizona (1992)
Imre Noth Photo 3

Imre Noth, Burr Ridge IL

View page
Specialties:
Pulmonologist
Address:
180 Harvester Dr, Burr Ridge, IL 60527
5841 S Maryland Ave, Chicago, IL 60637
Education:
University of Arizona, College of Medicine - Doctor of Medicine
Bernard Mitchell Hospital-University of Chicago Hospitals - Fellowship - Pulmonary Disease and Critical Care Medicine (Internal Medicine)
Board certifications:
American Board of Internal Medicine Sub-certificate in Critical Care Medicine (Internal Medicine)

Resumes

Resumes

Imre Noth Photo 4

Professor Of Medicine

View page
Location:
Chicago, IL
Industry:
Medical Practice
Work:
University of Chicago
Associate Professor
Education:
University of California, Davis - School of Medicine 1992 - 1995
University of Arizona, College of Medicine 1988 - 1992
MD, Medicine
Georgetown University 1987 - 1988
MS, Human Phsyiology
University of Pennsylvania 1983 - 1987
BA, Chemistry
Skills:
Clinical Research
Medical Education
Medicine
Internal Medicine
Translational Research
Cancer
Science
Board Certified
Data Analysis
Neuroscience
Life Sciences
Clinical Trials
Hospitals

Business Records

Name / Title
Company / Classification
Phones & Addresses
Imre Noth
Imre Noth MD
Internist
5841 S Maryland Ave, Chicago, IL 60637
(773) 702-9200

Publications

Us Patents

Marker Panels For Idiopathic Pulmonary Fibrosis Diagnosis And Evaluation

View page
US Patent:
20120035067, Feb 9, 2012
Filed:
Mar 3, 2011
Appl. No.:
13/039989
Inventors:
Naftali Kaminski - Pittsburgh PA, US
Kevin F. Gibson - Gibsonia PA, US
Bernadette R. Gochuico - Potomac MD, US
Thomas J. Richards - Pittsburgh PA, US
Ivan Rosas - Pittsburgh PA, US
Kazuhisa Konishi - Kyoto, JP
Moises Selman - Mexico D.F., MX
Imre Noth - Chicago IL, US
International Classification:
C40B 30/04
C40B 40/06
C40B 40/10
G01N 33/573
US Classification:
506 9, 435 74, 506 16, 506 18
Abstract:
The present invention relates to the discovery that of a panel of serum or plasma markers may be used to diagnose Idiopathic Pulmonary Fibrosis (“IPF”) and distinguish this condition from other lung ailments. It further relates to the identification of markers associated with IPF disease progression.

Nebulized Pharmaceutical Compositions For The Treatment Of Bronchial Disorders

View page
US Patent:
20060014698, Jan 19, 2006
Filed:
Jul 14, 2005
Appl. No.:
11/182279
Inventors:
Michael O'Connor - Wilmette IL, US
Edward Naureckas - Oak Park IL, US
Imre Noth - Chicago IL, US
International Classification:
A61K 38/05
A61K 31/737
US Classification:
514018000, 514054000
Abstract:
The present invention provides methods and pharmaceutical compositions for the treatment of bronchial disorders by inhalation therapy. In various embodiments, the active ingredient of the pharmaceutical compositions is one or more of a sulfated pentasaccharide and a peptidomemtic of a tripeptide. In various embodiments, the active ingredient of the pharmaceutical compositions is one or more of argatroban and fondaparinux.

Compositions And Methods For Predicting Lung Function Decline In Idiopathic Pulmonary Fibrosis

View page
US Patent:
20220291231, Sep 15, 2022
Filed:
Jan 13, 2020
Appl. No.:
17/422033
Inventors:
- Charlottesville VA, US
Imre Noth - Charlottesville VA, US
International Classification:
G01N 33/68
Abstract:
Provided are methods for generating prognostic signatures for subject diagnosed with Idiopathic Pulmonary Fibrosis (IPF) with respect to decline in lung Forced Vital Capacity (FVC). The methods can include determining first expression levels for one or more genes as set forth herein in a first biological sample obtained from a subject diagnosed with IPF, determining a second expression level for the same one or more genes in a second biological sample obtained from the subject, and comparing the first and second expression levels for the one or more genes to provide a prognostic signature. The first and second biological samples can include peripheral blood mononuclear cells (PBMCs) and/or nucleic acids extracted from PBMCs. Also provided are methods for classifying subjects with IPF as being at risk for FVC decline, for identifying and treating at risk subjects, and for monitoring the progress of treatments.

Marker Panels For Idiopathic Pulmonary Fibrosis Diagnosis And Evaluation

View page
US Patent:
20140335547, Nov 13, 2014
Filed:
May 14, 2014
Appl. No.:
14/277194
Inventors:
- D.F. Mexico, MX
- Bethesda MD, US
- Chicago IL, US
- Pittsburgh PA, US
Ivan Rosas - Pittsburgh PA, US
Kazuhisa Konishi - Pittsburgh PA, US
Moises Selman - Coyoacan, MX
Imre Noth - Chicago IL, US
Assignee:
Instituto Nacional De Enfermedades Respiratorias Ismael Cosio Villegas - D.F. Mexico
United States Of America, Secretary, Dept. Of Health And Human Services - Bethesda MD
The University Of Chicago - Chicago IL
University Of Pittsburgh - Of The Commonwealth System Of Higher Education - Pittsburgh PA
International Classification:
G01N 33/573
US Classification:
435 792, 435 71
Abstract:
The present invention relates to the discovery that of a panel of serum or plasma markers may be used to diagnose Idiopathic Pulmonary Fibrosis (“IPF”) and distinguish this condition from other lung ailments. It further relates to the identification of markers associated with IPF disease progression.
Imre Noth from Charlottesville, VA, age ~58 Get Report